SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Olecranon
To: Fitzhughlaw who wrote (62786)4/8/2025 9:37:41 AM
From: Fitzhughlaw1 Recommendation   of 63303
 
This is why I looked askance at some of the cheering from the peanut gallery about how SAVA's attorneys had "ripped the Magistrate a new one" and Matt Nachtrab's mischaracterization of the former defendants' lawsuit against SAVA for malicious prosecution and abuse of process. I could NEVER see a rationale for the initiation of SAVA's action (and as you'll recall, the company's hotshot attorneys ended up getting their asses kicked, having to eventually dismiss that case and leave the courthouse whimpering). Now the former defendants have SAVA on the run, and with good reason....

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug
NEW YORK, March 26 (Reuters) - The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and short-sellers who expressed doubts about its experimental, soon-to-be-discontinued Alzheimer's drug simufilam.
U.S. District Judge Jennifer Rochon in Manhattan said Adrian Heilbut, Jesse Brodkin, Enea Milioris, David Bredt and Geoffrey Pitt could try to prove that Cassava knew or should have known that it could not win its defamation lawsuit against them, which it dismissed in August.

reuters.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News